Many molecules induce the ectopic expression of tissue-speci®c genes in Xenopus embryos. Conversely, interfering with their activity disrupts patterns of gene expression, implicating them in normal development. Does this mean that they control cell fate (i.e. position, as well as differentiation)? Xsox17a and b can induce ectopic expression of endodermal markers; inhibiting their function suppresses expression of endodermal marker genes in the developing gut (Cell 91 (1997) 397). Here we show the effect of these manipulations on cell lineage. Expressing Xsox17 in a cells normally fated to become ectoderm causes their descendants either to relocate into the embryonic gut or to die at a late developmental stage. Conversely, disrupting Xsox17 activity in cells normally fated to be endodermal causes them to enter mesodermal and ectodermal lineages. q
Introduction
Fate maps have been constructed using lineage-labelled single blastomeres at the 32-cell stage of Xenopus embryogenesis (Dale and Slack, 1987; Moody, 1987) ; these are statistical, representing the probability that each blastomere will contribute progeny to a range of tissues (Fig. 1) . The nature of these maps indicates that the fate of a cell is determined predominantly by its position, but is not strictly lineage-dependent. Beyond this, the maps do not reveal the mechanisms underlying cell fate decisions, which are likely to include the inheritance of localised determinants, and both short and long range signals.
These maps are potentially extremely valuable in assessing the role of molecules affecting the fate of cells in the embryo, and enable us to determine whether expression of single genes can change this fate, something which requires activating programs of cell movement, differentiation and positional determination. Previously it has been shown that disrupting all kinds of TGF-b family signalling changes the cell fate of presumptive endoderm to mesoderm or nervous system (Hemmati-Brivanlou and Melton, 1994) . Here we investigate the effects of a single, endodermally restricted transcription factor that normally acts cell-autonomously to induce endodermal genes (Hudson et al., 1997) .
We have previously demonstrated that ectopic expression of Xsox17a or -b in animal cap explants results in the induction of endoderm markers. Conversely, inhibition of Xsox17 activity with a dominant negative derivative of Xsox17, made by fusing the DNA-binding HMG domain of Xsox17b to the repressor domain of the Drosophila transcription factor Engrailed (Xsox17::En R ), inhibited endodermal marker gene expression in the whole embryo, as well as in activin induction of endoderm (Hudson et al., 1997) . During this work we noticed that embryos made to express Xsox17b::En R ubiquitously by microinjecting mRNA at the 2-cell stage revealed an unusual abundance of cells containing large yolk platelets in tissues such as somites, notochord and epidermis. Such platelets are characteristic of cells of the vegetal pole and hence normally are inherited only by endoderm (see Fig. 1 ). This suggested that blocking Xsox17 activity had diverted these cells away from positions in endodermal lineages. We have tested if Xsox17a and b function as`master switches' for endodermal cell fate;`fate' includes the location of cells in the embryo, as well as their differentiated cell type. To do this we have used a lineage tracer (nuclear b-galactosidase mRNA, Smith and Harland, 1991) at the 32-cell stage of embryogenesis. We ®nd that expression of Xsox17 causes ectodermal cells, whose fate would not normally be endoderm, either to contribute to the gut or to die. Conversely, Xsox17b::En R expression diverts presumptive endodermal cells away from the gut and into mesodermal and ectodermal derivatives.
Results and discussion

Experimental strategy
Synthetic mRNAs were injected into a single blastomere, chosen randomly from a particular tier at the 32-cell stage, and embryos cultured to swimming tadpoles (usually stage 42), which is about a day before feeding. Compared to other organs, morphogenesis of the gut begins relatively late in embryogenesis, its characteristic coiling ®rst beginning at stage 42. At this stage it becomes possible to determine whether clones of labelled cells in the endoderm are contributing to a morphologically normal gut structure. The fate map of Dale and Slack (1987) , (reproduced in Fig. 1); shows that blastomeres at the animal pole of the 32-cell embryo, the A tier, are normally extremely unlikely to contribute to the gut. Conversely those of the vegetal D tier predominantly contribute to endoderm, and very rarely to ectoderm (Dale and Slack, 1987) . At stage 42, control embryos injected only with b-galactosidase mRNA showed the distribution of marked cells expected from the fate map of Dale and Slack (1987) (Fig. 2A±C) . The lineage marker mRNA encodes a b-galactosidase targeted to the nucleus (Smith and Harland, 1991) ; this was clearly detectable until at least stage 44, and could easily be distinguished from the very low level of non-nuclear endogenous b-galactosidase activity in the gut. A small proportion of injected embryos showed no staining; we attribute this to death of the injected cell and do not include these embryos in our analyses.
Xsox17 expression directs cells into the endoderm
The D tier normally gives rise predominantly to endoderm, with a small contribution to mesodermal tissues such as somite and heart (Dale and Slack, 1987;  Fig. 1 ). Most D-tier progeny will express Xsox17a and b from MBT in normal embryos. Injection of Xsox17b into a D tier blastomere results in an exclusive contribution of the marked progeny of this blastomere to the endoderm ( Fig.  2A) . The clones of labelled cells in the gut are comparable in size and distribution to control clones. Thus injection of 200 pg of this synthetic transcript into a single blastomere at the 32-cell stage does not appear to have any non-speci®c toxic effects. However, these embryos differ from the controls in that there is now no contribution of the labelled cells to the mesoderm.
In control embryos labelled progeny from A tier injections were mainly epidermal and neural ( Fig. 2A,C ), as Dale and Slack (1987) showing the contribution of blastomeres at the 32-cell stage to a range of tissues.
expected (Dale and Slack, 1987) . When assessed at stage 42, injection of 200 pg of Xsox17b message into an A tier blastomere has two effects; there are no labelled cells in the epidermis or nervous system at stage 42, and the majority of labelled cells that remain are situated in the gut (100% of embryos with labelled cells, n 54; Figs. 2A,C and 3A,B). These observations must be interpreted as a shift in fate of the A tier progeny, from epidermal/neural to endodermal, since no contribution of A tier cells to endoderm was evident in the control embryos.
The lineage-labelled gut cells appear histologically normal (Fig. 3C ) and can be seen to contribute to most regions of the mid-and hindgut. The clone size in these embryos is variable, and is smaller than in the control embryos, suggesting that some cell death has occurred (see below). Injection of Xsox17a transcripts has effects identical to those of Xsox17b (n 20, not shown). Despite the injection of transcripts known to cause developmental abnormalities when injected bilaterally at the 2-cell stage, embryos resulting from these injections are nearly all morphologically normal; the embryo as a whole is therefore able to compensate successfully for the change in fate of the injected cell's progeny.
Since the cells derived from the A tier would normally be found on the surface of the embryo or in the nervous system, relocation into the developing gut represents a radical change in position. We ®nd that these cells behave as normal A tier descendants until stage 12, that is, near the end of gastrulation. After this point, rather than dispersing and intermixing with neighbours as occurs with clones in control injected blastomeres, the labelled cells appear to aggregate into dense`swirls' (Fig. 4A,B) . Given the appearance of these swirls, it is remarkable that unstained sister embryos look and develop normally.
When the embryos are examined at stage 30±32, signi®-cant numbers of these labelled super®cial cells can still be seen (Fig. 4D) , although fewer than in the control embryos (Fig. 4C) ; these cells disappear gradually during stages 30± 40 and by stage 42 none remain. The only reasonable interpretation of this observation is that the cells are dying. Since the resulting embryos appear normal, with no sign of epidermal lesions, this suggests that the loss of cells is via a regulated process, i.e. apoptosis ± which has been shown to occur naturally in the Xenopus embryo (Hensey and Gautier, 1998) ± rather than necrosis. However, whole-mount in situ endlabelling assays (TUNEL assays) failed to detect a signi®cant increase in apoptotic cells amongst the labelled population. This may be a consequence of the long time period (several days) over which these cells are dying, such that very few are undergoing apoptosis at any single time point.
We conclude that the progeny of the A-tier cells expressing Xsox17 either move into an endodermal environment, or die by some unknown mechanism; these cells are unable to contribute to ectodermal derivatives.
How do the cells become relocated into the gut? Cell movement and mixing occurs during gastrula and neurula (1111) to`low' (1). These data were then converted into the histograms above (although only representative examples of tissues are shown). Although a somewhat subjective approach, data from large numbers of embryos can be represented in this way, and the results from control embryos agree well with published fate maps. stages, and it may be suf®cient to bring A tier descendants into contact with the endoderm lineage. If, as a consequence of Xsox17 expression, these cells carry surface markers which identify them as endodermal, rather than epidermal or neural, then they may become interspersed with the endoderm cells. In addition they might lose ectodermal adhesive molecules, which would facilitate their movement inwards (we have previously demonstrated down-regulation of one epidermal marker ± epidermal cytokeratin ± in animal caps expressing Xsox17; Hudson et al., 1997) . The ability of embryonic cells to`sort' in this manner has been well documented (e.g. Townes and Holtfreter, 1955) ; these data suggest a role for Xsox17 in this process, and hence in positioning cells in the embryo, and this conclusion is supported by over-expression in cells of the other three tiers.
A proportion of C tier cells will normally contribute to endoderm, but there is also a substantial contribution to mesoderm, mainly evident in the somites (Fig. 2B) . However a C tier cell injected with Xsox17b mRNA contributes progeny almost exclusively to the gut, so in this context endodermal development overrides the normal process of mesoderm induction (Fig. 2B) . The B tier also contributes substantially to mesoderm, as well as to ectoderm. While Xsox17 markedly increases the proportion of the daughter cells in the gut, signi®cant numbers remain in the mesoderm, and so there appears to be a tier-dependent hierarchy in the relationship between mesoderm and endoderm (Fig. 2B) . However, B and C tier cells are not equivalent in terms of the likelihood that they will contribute to endoderm under normal circumstances. It is possible that the inheritance of maternal determinants such as Vg1 (Joseph and Melton, 1998) and VegT (Zhang et al., 1998 ) by C tier progeny, which in normal embryos probably direct a proportion of them into the endoderm, may make the remainder more vulnerable than B tier progeny to respeci®cation by Xsox17.
Xsox17::En R expression diverts cells away from the endoderm
The converse of the experiments just outlined is to disrupt Xsox17 activity, particularly in the D tier, which forms most of the endoderm. Injection of 50 pg Xsox17b ::En R mRNA into an A-, B-or C tier blastomere results in a distribution of progeny similar to that in control embryos ( Fig. 2A,B) . This is not unexpected, but excludes the possibility that the message is toxic and argues for the speci®city of effects seen in D tier progeny. Some of the progeny of an injected D tier blastomere remain in the gut, but this is a smaller proportion than in a control D tier blastomere. The remainder contributes to such tissues as epidermis, and mesodermal derivatives such as somites and heart (Fig. 3D,E ). This is a far greater proportion than seen in any control embryo. We interpret this result to mean that inhibition of Xsox17 activity markedly reduces the probability that a cell will contribute to endoderm. In this case the change in fate does not affect all of the labelled cells; we may be unable to completely block wild-type Xsox17 activity in these cells because of competition between the endogenous protein and the repressor fusion for sites on promoters of target genes. The equilibrium reached between these factors could determine whether any particular cell would contribute to the endoderm lineage, or be excluded from it. Injection of increased amounts of Xsox17b ::En R transcript does not increase the proportion of`shifted' cells, but rather results in toxic effects such as cell death and abnormal morphology (not shown). Xsox17-a ::En R has effects similar to Xsox17b::En R , and combined injection of Xsox17b ::En R and Xsox17a ::En R has no greater effect than injecting these transcripts individually (not shown).
D tier-derived cells containing Xsox17b::En R show aberrant behaviour from an early stage. In control embryos these cells are internalised through the blastopore with the vegetal yolk mass, remaining in the endoderm throughout embryogenesis. When expressing the repressor fusion the labelled cells remain internal until stage 12, as in controls (Fig. 4E±  H) , but begin to appear super®cially during neurula stages (Fig. 4J) . It is possible that these cells are not recognised as endodermal by their neighbours, and hence are expelled from, or move from, the endodermal mass. Alternatively, or in addition, they may preferentially adhere to cells in the mesoderm or ectoderm. This relatively late movement indicates that the fate of these cells is labile for longer than is suggested by cell transplantation experiments (Wylie et al., 1987 ).
Previously we have been able to demonstrate that Xsox17 expression induced a range of endoderm markers (endodermin, HNF-1b , Xlhbox8, IFABP). Here we show that expression of Xsox17 is suf®cient to commit cells to the endoderm lineage, even though the cells concerned are initially in thè wrong' part of the embryo. Ectopic expression of Xsox17 does not, however, result in the formation of patches of ectopic endoderm. Rather the labelled cells survive to stage 42 only if they are incorporated into the natural endoderm. This implies that these cells require the environment provided by the endodermal mass in order to survive. The speci®cation of endoderm thus has at least these two components; correct spatial activation of Xsox17 expression in presumptive endodermal cells, and provision of a permissive environment within the endodermal mass for their continued development.
Experimental procedures
Embryo manipulation
Embryos were obtained and handled as described previously (Hudson et al., 1997) . For injection, embryos were cultured in 3% Ficoll in 1/10 Barth's medium. Embryos with regular cleavage were injected in a single blastomere at the 32-cell stage with Xsox17a or b ,or Xsox17b ::En R or Xsox17a ::En R , and b -galactosidase mRNAs.
Transcriptions for injection
All transcriptions were carried out using mMessage mMachine (Ambion) and were dissolved in water for injection. b-Galactosidase transcripts were generated by XhoI digestion of SP6nuc-Beta-gal (Smith and Harland, 1991) , followed by SP6 transcription. Xsox17b ::En R and Xsox17a ::En R were derived from pSPXsox17b::En R and pSPXsox17a::En R , respectively by XhoI digestion and SP6 transcription. Xsox17a and -b RNAs were transcribed from pSPXsox17a and pSPXsox17b respectively using SP6 and XhoI-linearized template.
b -gal staining
Injected embryos were cultured to the required stage, then ®xed for 30 min in MEMFA (0.1 M MOPS pH7.4, 2 mM EGTA, 1 mM MgSO 4 , 3.7% formaldehyde). b-Galactosidase expression was detected by incubation in b-gal buffer (0.1 M NaPi, pH7.2, 2 mM MgCl 2 , 0.02% NP-40, 0.01% Na deoxycholate, 5 mM potassium ferricyanide, 5 mM potassium ferrocyanide, 1 mM EGTA) with 0.4 mg/ml X-gal at 378C for at least 2 h. The embryos were then re-®xed in MEMFA at 48C overnight, dehydrated through an ethanol series, and cleared for photography in Murrays'¯uid (1:1 benzyl benzoate:benzyl alcohol). Embryos for histology were embedded in Paraplast and sectioned at 10 mm.
